Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25‐dihydroxyvitamin D3
暂无分享,去创建一个
P. Brachet | G. Labourdette | D. Baas | S. Kuchler-Bopp | Dominique Baas | Kirsten Prüfer | Marie Elisabeth Ittel | Sabine Kuchler‐Bopp | Gérard Labourdette | Louis L. Sarliève | Philippe Brachet | K. Prüfer | L. Sarliève | M. Ittel
[1] A. Warrington,et al. The oligodendrocyte and its many cellular processes. , 1993, Trends in cell biology.
[2] J. Matthieu,et al. Myelin/oligodendrocyte glycoprotein expression during development in normal and myelin-deficient mice. , 1990, Developmental neuroscience.
[3] G. Jirikowski,et al. 1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus. , 1997, Cellular and molecular biology.
[4] D. Muir,et al. CG‐4, A new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type‐2 astrocytes , 1992, Journal of neuroscience research.
[5] H. DeLuca,et al. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.
[6] A. Mackay,et al. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[7] M. Somerville,et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.
[8] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[9] G. Labourdette,et al. Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro , 1987, Neuroscience Letters.
[10] G. Miller,et al. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. , 1996, Endocrinology.
[11] H. DeLuca,et al. Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Carswell,et al. Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain , 1994, Brain Research.
[13] J. Vallat,et al. Platelet‐derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin‐like membranes repair in vitro , 1996, Glia.
[14] K. Umesono,et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.
[15] W. Rutter,et al. Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor , 1983, Nature.
[16] P. Brachet,et al. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. , 1996, Brain research. Molecular brain research.
[17] M. Walters. Newly identified actions of the vitamin D endocrine system. , 1992, Endocrine reviews.
[18] P. Brachet,et al. 1,25 Dihydroxyvitamin D3 Exerts Regional Effects in the Central Nervous System during Experimental Allergic Encephalomyelitis , 1996, Journal of neuropathology and experimental neurology.
[19] P. Albert,et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. , 1995, Journal of immunology.
[20] B. Zalc,et al. Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition , 1996, Glia.
[21] J. Puymirat,et al. Transient expression of 3,5,3′‐triiodothyronine nuclear receptors in rat oligodendrocytes: In vivo and in vitro immunocytochemical studies , 1994, Journal of neuroscience research.
[22] M. Noble,et al. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. , 1996, Developmental biology.
[23] J. Adams,et al. 1,25‐Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein‐specific T cell clone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] N. Ibarrola,et al. Stimulation of the myelin basic protein gene expression by 9-cis-retinoic acid and thyroid hormone: activation in the context of its native promoter. , 1999, Brain research. Molecular brain research.
[25] J. Pike,et al. Vitamin D3 receptors: structure and function in transcription. , 1991, Annual review of nutrition.
[26] R. Skoff,et al. Oligodendrocytes in female carriers of the jimpy gene make more myelin than normal oligodendrocytes , 1995, The Journal of comparative neurology.
[27] G. Labourdette,et al. Oligodendroglia content of glial cell primary cultures, from newborn rat brain hemispheres, depends on the initial plating density , 1980, Neuroscience Letters.
[28] J. Puymirat,et al. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone , 1997, Glia.
[29] H. DeLuca,et al. Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.
[30] A. Rodríguez-Peña,et al. Oligodendrocyte development and thyroid hormone. , 1999, Journal of neurobiology.
[31] R. Houlgatte,et al. 1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.
[32] M. Ghandour,et al. Cultures from rat brain hemispheres enriched in oligodendrocyte-like cells , 1979, Brain Research.
[33] K. Ozono,et al. Perspectives: The genomic mechanism of action of 1,25‐dihydroxyvitamin D3 , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] B. Pettmann,et al. Retinoic acid regulates the development of oligodendrocyte precursor cells in vitro , 1994, Journal of neuroscience research.
[35] J. Vallat,et al. Investigation of myelination in vitro: polar lipid content and fatty acid composition of myelinating oligodendrocytes in rat oligodendrocyte cultures , 1990, Neurochemistry International.
[36] S. Brimijoin,et al. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.
[37] M. Galligan,et al. Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Labourdette,et al. UPD-galactose:Ceramide galactosyltransferase activity in dissociated cell cultures from brain hemispheres of newborn rats , 1980, Neuroscience Letters.
[39] M. Haussler,et al. Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. , 1993, The Journal of biological chemistry.
[40] P. Brachet,et al. 1,25‐Dihydroxyvitamin D3 Regulates the Synthesis of γ‐Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes , 1999, Journal of neurochemistry.
[41] J. Puymirat,et al. Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3′-triiodo-l-thyronine , 1994, Neuroscience Letters.
[42] N. Bhat,et al. Cytokine Induction of Inducible Nitric Oxide Synthase in an Oligodendrocyte Cell Line , 1999, Journal of neurochemistry.
[43] J. Puymirat,et al. Expression of α and β thyroid receptors during oligodendrocyte differentiation , 1994 .
[44] P. Brachet,et al. Synthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro , 1994, Journal of neuroscience research.
[45] C. Demerens,et al. Thyroid hormone receptor isoforms are sequentially expressed in oligodendrocyte lineage cells during rat cerebral development , 1998, Journal of neuroscience research.
[46] J M Lemire,et al. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.
[47] C. Campagnoni,et al. Structure and expression of the mouse myelin proteolipid protein gene , 1987, Journal of neuroscience research.
[48] H. DeLuca,et al. Recent advances in the molecular biology of vitamin D action. , 1996, Progress in nucleic acid research and molecular biology.
[49] H. DeLuca,et al. A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. de Vellis,et al. CNS glial cells express neurotrophin receptors whose levels are regulated by NGF. , 1993, Brain research. Molecular brain research.
[51] M. Saarma,et al. Regulatory elements and transcriptional regulation by testosterone and retinoic acid of the rat nerve growth factor receptor promoter. , 1992, Gene.
[52] P. Brachet,et al. 1,25‐dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro , 1998 .
[53] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[54] E. Brown,et al. A rapid and simple one step method for isolation of poly(A)+ RNA from cells in monolayer. , 1990, Endocrinology.
[55] P. Brachet,et al. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.
[56] P. Brachet,et al. Differential expression of M‐CSF, LIF, and TNF‐α genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D , 1996, Journal of neuroscience research.
[57] P. Brachet,et al. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. , 1997, Brain research. Molecular brain research.
[58] R. Dobrowsky,et al. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75 , 1996, Nature.
[59] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Sutcliffe,et al. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. , 1988, DNA.
[61] E. Shooter,et al. Gene transfer and molecular cloning of the rat nerve growth factor receptor , 1987, Nature.
[62] T. Kawada,et al. Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. , 1993, Biochemical and biophysical research communications.
[63] P. Brachet,et al. Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25‐dihydroxyvitamin D3 , 1998, Glia.
[64] M. Atchison,et al. Small basic proteins of myelin from central and peripheral nervous systems are encoded by the same gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Norman,et al. Vitamin K-dependent γ-carboxylation of the 1,25-dihydroxyvitamin D3 receptor , 1992 .
[66] M. Lazar,et al. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. , 1994, Development.
[67] H. Koeffler,et al. Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. , 1987, The Journal of biological chemistry.
[68] G. Labourdette,et al. Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes , 1989, International Journal of Developmental Neuroscience.
[69] T. Veenstra,et al. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.
[70] M. Haussler,et al. Development of hybridomas secreting monoclonal antibodies to the chicken intestinal 1 alpha,25-dihydroxyvitamin D3 receptor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Noble,et al. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[72] A. Dace,et al. Calcitriol is a positive effector of adipose differentiation in the OB 17 cell line: relationship with the adipogenic action of triiodothyronine. , 1997, Biochemical and biophysical research communications.
[73] C. Glass,et al. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.